Navigation Links
New Leadership Team at International Trachoma Initiative to Build Stronger Partnerships to Eliminate Blinding Trachoma
Date:7/1/2009

extensive public health program management and evaluation experience, with an emphasis on trachoma and other NTDs in Africa.
  • Supply Chain Manager Vivian Singletary has worked over 15 years on managing supply chain optimization projects, including mid- to long-term strategy, IT system implementations and process improvement.
  • Project Manger PJ Hooper, who oversees a Gates Foundation grant supporting NTD integration research, has conducted operational research on Lymphatic Filariasis and NTDs for another Gates grant to the Global Alliance to Eliminate LF.
  • Program Accounting Manager Edward Nyankson has 16 years experience in accounting and financial reporting, tax, securities exchange and regulatory reporting.

    • ITI has program offices in Ethiopia, Ghana, Mali, Niger, Tanzania and Vietnam.

    www.trachoma.org


    '/>"/>
    SOURCE The International Trachoma Initiative (ITI)
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2

    Related biology technology :

    1. N.C. Takes Biofuels Leadership, Establishes New Endeavor With $5 Million State Appropriation
    2. Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry
    3. KGI and Smith College Establish Leadership Forum for Women in Bioscience
    4. Campbell Alliance Managed Markets Practice to Take Leadership Role at CBIs Formulary and Reimbursement Conference
    5. Assay Designs(TM) Announces Additions to the Leadership Team
    6. Deloitte Leadership Offers Crucial Convergence Considerations for Life Sciences Companies
    7. Dr. Dinesh Verma to be honored with Presidents Leadership Award at Edwin A. Stevens Society Gala
    8. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
    9. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
    10. PharmAthene Enhances Executive Leadership Team and Appoints Joan Fusco, Ph.D. Senior Vice President of Operations
    11. Halogen Announces Record Year - Company Solidifies Leadership Position, Secures Strategic Wins Over Competition

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/6/2009)...BROOK, N.Y., Nov. 6 BioS...opharmaceutical company developing first-in-class ...nancial results for the third quarter ended Septem..., in September of this year, the FDA,s Arthritis A...te of 12-0, the approval of XIAFLEX(TM) for the tr...
    (Date:11/6/2009)... VIENNA, Austria, November 6 EUCOD...manufacturing, and marketing enzymes for the,chemi...nto a research,agreement with Bio Sidus, the leadi..., The agreement gives EUCODIS Bioscience exc...est - to Bio Sidus, proprietary collection of,psyc...
    (Date:11/6/2009)...GARY, Nov. 6 /PRNewswire-FirstCall/ - Oncolytics B...r the "Company") today announced updated results f... patients with sarcomas metastatic to the lung in ...e Tissue Oncology Society Meeting held in Miami Be... presentation, entitled "A Phase II Study of Intra...
    (Date:11/5/2009)...SPORTATION -- Gone hybrid . . . , Fuel economy...re now posted at the www.fueleconomy.gov web sit...nd maintains for the U.S. Department of Energy and... the top 10 vehicles on the best fuel economy list... MPG city; 48 highway). "This list proves that hyb...
    Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
    ...to restoring injured Veterans to their greatest po...unities, and work places. For those who lost limbs...uch as diabetes, VA researchers are designing and ...eading-edge technologies such as robotics, tissue ...how to best match available prosthetic components ...
    ...ate,s economic successes , , RESEARCH TRIANGLE PA... flu is shining a spotlight on North Carolina,s lo...l pharmaceutical giant GlaxoSmithKline, with North...is one of the world,s two key manufacturers of ant...ant in Zebulon, about 25 miles east of its headqua...
    ... CVD ) today reported earnings for its first quar...e versus $0.76 per diluted share in the first quar...uding the centralized ECG gain on sale). , , "On...grew 7.0% (13.8% excluding the impact of foreign e...EPS of $0.63 met our first quarter expectation," s...
    Other Biology Technology:Video: Turning Hope Into Reality - VA Research to Restore Veterans' Abilities 2Video: Turning Hope Into Reality - VA Research to Restore Veterans' Abilities 3NC Biomanufacturers Supply Defense for World vs. Flu 2Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 2Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 3Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 4Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 5Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 6Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 7Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 8Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 9Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 10Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 11Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets 12
    (Date:11/4/2009)...ct. 23 GenVault Corporation, the l...for genomic discovery, medicine and identification...lt,s President and CEO, will be presenting at the ... 26th and 27th in La Jolla, CA. ,, During the p...f the company together with recent customer, techn...
    (Date:11/4/2009)...Newswire/ -- Glencoe Software, Inc., the commercia...sortium ( http://openmicroscopy.org ), is proud ...ciety of Cell Biology,s exciting new project title...awarded a $2.5M stimulus grant through the Nationa... program, as part of the American Reinvestment and...
    (Date:11/3/2009)...r labeling of fruit and vegetables is a new, paten...e laser beam is used to label, or "etch" informati...mmon sticker-type labels. The technology has been ...bles and is being used in New Zealand, Australia, ...ed in Asia, South Africa, Central and South Americ...
    Breaking Biology News(10 mins):GenVault Corporation to Present at the 2009 BIOCOM Investor Conference 2Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Laser etching safe alternative for labeling grapefruit 2Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 1Madzone Marketing LLC Taps TransMedia Group to Provide Publicity Lift to Knife and Forklift 28TM 29 53445 2Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 1Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 2Jatropha Couple Oil Crop Cultivation Technology Commercially Released 13320 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 1Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 2Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 3Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 4Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on 4809 5
    ... meerkats subject their subordinates to escalating... become overly stressed and as a result infertile,...at during the latter half of her pregnancy, the do...er subordinate females from the group for an avera...nates, typically those with whom reproductive conf...
    ...researchers has found that people with long-standi...rea of the brain responsible for voluntary movemen...ted out of the brain to a computer and converted i...form basic tasks. , In the 13 July 2006 issue of...ed results from the initial participants in a clin...
    ...am who - 10 years ago - created the cloned sheep "...n of Pharmaceutical Scientists, (AAPS) National Bi...the meeting, nearly two-thousand of the world,s le...l issues affecting pharmaceutical biotechnology in...as the next revolution in healthcare. , "At AAPS, ...
    Other Biology News:Dominant meerkats render rivals infertile 2Brain-computer link lets paralyzed patients convert thoughts into actions 2Brain-computer link lets paralyzed patients convert thoughts into actions 3Brain-computer link lets paralyzed patients convert thoughts into actions 4Brain-computer link lets paralyzed patients convert thoughts into actions 5Ten years later, Dolly is still making headlines 2
    ...e NOVOstar is an exciting product for cell-based k..., cell-based assays required the use of expensive ... for scientists in the assay development stage. Th...r cell-based assays as well as any other assay sui...
    ...e Digital Clamp One can operate as a Voltage Clamp... Clamp in electrophysiology research applications....ional analog equipment. • This amazing in...in the capabilities of Digital Signal Processing (...
    Dispensing Bins from Terra Universal, Inc.
    Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
    Biology Products: